(Es)ketamine's Role in Functional Neurological Disorder

Potential of (Es)ketamine in Treating Functional Neurological Disorder

Recent systematic reviews suggest that (Es)ketamine may offer therapeutic benefits for functional neurological disorder (FND), a condition with few effective treatments. FND is characterized by symptoms like functional motor and dissociative seizures, which are often resistant to conventional therapies. The review, conducted through databases such as PubMed and PsycINFO, highlights anecdotal improvements in symptoms following (Es)ketamine administration.

Mechanisms and Context of (Es)ketamine Use

(Es)ketamine, a derivative of ketamine, is increasingly used in treating various neuropsychiatric conditions due to its rapid-acting antidepressant effects. In the context of FND, the review identified 13 studies, mainly case reports and small case series, reporting symptom improvement. However, the studies' uncontrolled and heterogeneous nature limits the ability to draw definitive conclusions about the efficacy of (Es)ketamine in FND.

Research Implications and the Need for Controlled Trials

The review underscores the necessity for prospective controlled trials to establish a clear understanding of (Es)ketamine's therapeutic role in FND. The current evidence base is insufficient due to methodological variability and potential biases, such as publication and expectancy bias. Controlled trials would help delineate whether symptom improvements are due to direct effects on FND symptoms or indirect benefits from psychiatric improvements.

Risks and Unknowns in (Es)ketamine Administration

While some studies report transient adverse effects in supervised settings, the safety profile of (Es)ketamine in FND remains inadequately characterized. The heterogeneity of diagnoses and outcomes further complicates the interpretation of its therapeutic potential. Understanding the specific mechanisms by which (Es)ketamine may affect FND symptoms is crucial for assessing both efficacy and safety.

Looking Forward: The Future of (Es)ketamine in FND Treatment

Despite the current limitations, the review suggests that further investigation into (Es)ketamine for FND is warranted. Future research should focus on well-designed, controlled trials to better understand its potential benefits and risks. Such studies could pave the way for more effective treatment options for FND, a condition that significantly impacts patients' quality of life.